Half of Men Over 30 Have Gum Disease.
Periodontal disease is the most common chronic inflammatory condition in adult men. It starts as gingivitis (gum inflammation) and progresses to periodontitis (gum recession with bone loss). By age 65, 70% of men have some degree of periodontal disease.
The consequences go beyond your teeth. Periodontal disease is independently associated with cardiovascular disease, diabetes progression, cognitive decline, and systemic inflammation. The bacteria and inflammatory mediators from diseased gums enter the bloodstream with every bite and brush.
The standard dental approach: scaling and root planing, antimicrobial rinses, and surgery for advanced cases. None of these interventions promote tissue regeneration. They remove disease but do not rebuild what was lost.
Peptides that promote mucosal healing, bone regeneration, and tissue repair target exactly what periodontal treatment leaves on the table.
BPC-157: Oral Mucosa Repair.
BPC-157 is derived from a protein in human gastric juice. The oral mucosa (mouth lining) and gastric mucosa share developmental origin and structural similarities. BPC-157's extensive gut mucosal healing research extends logically to oral tissue.
Oral BPC-157 administration provides direct contact with gum tissue. Unlike systemic administration, oral dosing bathes the periodontal tissue in the peptide during the swallowing process. This is one of the few applications where the oral route provides better local exposure than injection.
For gum recession: Oral BPC-157 250-500 mcg held briefly in the mouth before swallowing, twice daily. This maximizes contact time with gum tissue while still providing systemic absorption.
For post-extraction healing: Oral BPC-157 250 mcg starting the day after extraction. The socket healing process is directly analogous to the gastric mucosal healing that BPC-157 research documents extensively.
GHK-Cu: Implant Integration and Bone Support.
Dental implants require osseointegration—the process of bone growing into and around the titanium implant surface. This takes 3-6 months and is the rate-limiting step in implant success.
GHK-Cu stimulates collagen synthesis, promotes tissue remodeling, and activates genes involved in bone metabolism. While dental-specific studies are limited, the mechanisms—osteoblast activation, collagen organization, anti-inflammatory modulation—are directly relevant to implant osseointegration.
Systemic GHK-Cu (1-2 mg subcutaneous daily) during the osseointegration period provides support through normal blood supply to the jaw. Combined with oral BPC-157 for soft tissue healing around the implant site.
Timeline: Start GHK-Cu 1 week before implant surgery. Continue through the 3-6 month osseointegration period. This is a long commitment for a long process.
The Dental Protocol.
Periodontal disease management: Oral BPC-157 250-500 mcg twice daily (hold in mouth briefly before swallowing). Continue alongside standard periodontal treatment. 8-12 week minimum protocols. Monitor gum pocket depths at dental checkups to track progress.
Post-extraction: Oral BPC-157 250 mcg twice daily starting day 1 post-extraction. Continue 2-4 weeks. Do not rinse vigorously or disturb the clot—gentle oral holding is sufficient.
Implant support: Oral BPC-157 + systemic GHK-Cu 1 mg daily. Start 1 week pre-surgery. Continue through osseointegration (3-6 months). Follow your oral surgeon's post-operative instructions precisely.
Wisdom tooth extraction: Oral BPC-157 250 mcg starting the day before extraction. Continue 1-2 weeks post-extraction. The anti-inflammatory and healing effects may reduce dry socket risk (the most common complication), though this has not been specifically studied.
Do not rinse with harsh mouthwash during active peptide protocols for oral tissue. Alcohol-based rinses can denature peptides on contact. Use gentle saltwater rinses if needed.
What Your Dentist Needs to Know.
Most dentists are unfamiliar with peptides. That is fine—you do not need their endorsement. But they need to know you are using compounds that may affect wound healing and tissue repair.
Frame it simply: "I am using oral peptide supplements that may affect tissue healing. I want you to be aware during any dental procedures."
The relevant information for your dentist: You are using something that promotes healing (they will want to know this post-procedurally). It does not interact with local anesthetics. It does not affect bleeding risk.
For oral surgeons performing extractions or implant placement, the same disclosure applies. They may have questions—direct them to the published BPC-157 research if they are interested.
◆ Key Takeaway
Oral BPC-157 provides direct mucosal contact with gum tissue for periodontal support, post-extraction healing, and implant site recovery. GHK-Cu supports osseointegration during dental implant healing. Hold oral BPC-157 briefly in the mouth before swallowing to maximize local exposure. Disclose peptide use to your dentist before procedures.